Evidence-based practice of palliative medicine / [edited by] Nathan E. Goldstein, R. Sean Morrison. (Text)Call no.: WB310 .E953 2013Publication: Philadelphia : Elsevier/Saunders, c2013Description: xxi, 499 p. : illISBN: 9781437737967 (pbk. : alk. paper)Subject(s): Evidence-based medicinePalliative care
|Book||Nongyao Chaiseri Library||General Books||General Stacks||WB310 .E953 2013 (เรียกดูชั้นหนังสือ)||พร้อมให้บริการ||มี E-book 1st ed./2013 ที่ฐานข้อมูล ClinicalKey||31379014194501|
Browsing Nongyao Chaiseri Library shelves ปิดตัวเรียกดูชั้นหนังสือ
|WB310 .C436 2018 The Changing face of volunteering in hospice and palliative care :||WB310 .C6685 2017 Compassionate communities :||WB310 .C686 2013 Counseling clients near the end of life : a practical guide for mental health professionals /||WB310 .E953 2013 Evidence-based practice of palliative medicine /||WB310 .P352 2011 Palliative care : core skills and clinical competencies /||WB310 .ก535 2552 ก่อนวันผลัดใบ :||WB310 .ก535 2560 รู้ให้รอบ ตอบเรื่องมาตรา 12 พ.ร.บ. สุขภาพแห่งชาติ พ.ศ. 2550 /|
Includes bibliographical references.
Chapter 1 How should opioids be started and titrated in routine outpatient settings? -- Chapter 2 How should opioids be started and titrated in hospital or inpatient settings? -- Chapter 3 How should patient-controlled analgesia be used in patients with serious illness and those experiencing postoperative pain? -- Chapter 4 How should opioids be used to manage pain emergencies? -- Chapter 5 What principles should guide oral, transcutaneous, and intravenous opioid dose conversions? -- Chapter 6 Which opioids are safest and most effective in renal failure? -- Chapter 7 How should methadone be started and titrated in opioid naïve and opioid-tolerant patients? -- Chapter 8 What special considerations should guide the safe use of methadone?
Chapter 9 When should corticosteroids be used to manage pain? -- Chapter 10 When should nonsteroidal antiinflammatory drugs be used to manage pain? -- Chapter 11 What is Neuropathic Pain? How do opoids and nonopoids compare for neuropathic pain management? -- Chapter 12 Should bisphosphonates be used routinely to manage pain and skeletal complications in cancer? -- Chapter 13 Should bisphosphonates be used routinely to manage pain and skeletal complications in other conditions? -- Chapter 14 When should radiotherapy be considered for pain management and what principles should guide the consideration of limited-fraction versus full-dose radiotherapy? -- Chapter 15 When should radiopharmaceuticals be considered for pain management?
Chapter 16 What principles should guide the prescribing of opioids for non-cancer-related pain? -- Chapter 17 What approaches should be used to minimize opioid diversion and abuse in palliative care? -- Chapter 18 When should epidural or intrathecal opioid infusions and pumps be considered for pain management? -- Chapter 19 When should nerve blocks be used for pain management? -- Chapter 20 What interventions are effective for managing dyspnea in cancer? -- Chapter 21 What is the role of opoids in treatment of refractory dyspnea in advanced COPD? -- Chapter 22 What nonopioid treatments should be used to manage dyspnea associated with COPD? -- Chapter 23 What interventions are effective for managing dyspnea in heart failure?
Chapter 24 What medications are effective in preventing and relieving constipation in the setting of opioid use? -- Chapter 25 How should medications be initiated and titrated to reduce acute and delayed nausea and vomiting in the setting of chemotherapy? -- Chapter 26 How should medications be initiated and titrated to prevent and treat nausea and vomiting in clinical situations unrelated to chemotherapy? -- Chapter 27 What interventions are effective for relieving acute bowel obstruction in cancer and other conditions? -- Chapter 28 What medications are effective in improving anorexia and weight loss in cancer? -- Chapter 29 What therapeutic strategies are effective in improving anoerexia and weight loss in nonmalignant disease?
Chapter 30 When should enteral feeding by percutaneous tube be used in patients with cancer and in patients with non-cancer-related conditions? -- Chapter 31 When should parenteral feeding be considered for patients with cancer and for patients with non-cancer-related conditions? -- Chapter 32 How does one assess for psychiatric illness in patients with advanced disease? -- Chapter 33 What treatments are effective for depression in the palliative care setting? -- Chapter 34 What treatments are effective for anxiety in patients with serious illness? -- Chapter 35 What is delirium? -- Chapter 36 What pharmacological treatments are effective for delirium? -- Chapter 37 What nonpharmacologic treatments are effective for delirium?
Chapter 38 What are the differences when treating a patient at the end of life with delirium (terminal delirium)? -- Chapter 39 How do symptoms change for patients in the last days and hours of life? -- Chapter 40 What is known about prognostication in advanced or serious illness? -- Chapter 41 What is a useful strategy for estimating survival in palliative care settings for persons with advanced cancer? -- Chapter 42 What is a useful strategy for estimating survival for persons with advanced non-cancer-related illness in palliative care settings? -- Chapter 43 What are the key elements to having a conversation about setting goals and communicating serious news? -- Chapter 44 What do palliative care clinicians need to know about teaching communication?
Chapter 45 What are advance care plans and how are they different than advance directives? -- Chapter 46 What elements are essential to effective advance care planning? -- Chapter 47 What is the evidence that advance care plans change patient outcomes? -- Chapter 48 What is the role for palliative care in patients with advanced cancer? -- Chapter 49 What is the clinical course of advanced cancer? -- Chapter 50 What is the relationship between patient performance status and ability to offer chemotherapeutic treatments? -- Chapter 51 What is the clinical course of advanced dementia? -- Chapter 52 What are appropriate palliative interventions for patients with advanced dementia? -- Chapter 53 What is the clinical course of advanced liver disease and what symptoms are associated with it?
Chapter 54 What special considerations are needed for treating patients with chronic liver disease? -- Chapter 55 What is the Role of Palliative Care in Stroke? -- Chapter 56 What special considerations are needed for individuals with amyotrophic lateral sclerosis, multiple sclerosis, or Parkinson Disease? -- Chapter 57 What is the clinical course of advanced heart failure and how do implanted cardiac devices alter this course? -- Chapter 58 What is chronic critical illness and what outcomes can be expected? -- Chapter 59 What special considerations are needed in patients with head and neck cancer? -- Chapter 60 What special considerations are needed in treating symptoms in patients with end-stage renal disease? -- Chapter 61 How is the patient who stops dialysis best managed?
Chapter 62 Which patients with end-stage renal disease should not be started on dialysis? -- Chapter 63 What is frailty? -- Chapter 64 What are the special needs of patients with frailty? -- Chapter 65 What are special considerations for treating pediatric patients and their families? -- Chapter 66 What are the signs and symptoms of spinal cord compression? -- Chapter 67 What are the best pharmacological and surgical treatments for patients with spinal cord compression? -- Chapter 68 What techniques can be used in the hospital or home setting to best manage uncontrollable bleeding? -- Chapter 69 What can be done for patients with crisis dyspnea? -- Chapter 70 What are the arguments that show that palliative care is beneficial to hospitals?
Chapter 71 What are the arguments that show that outpatient palliative care is beneficial to medical systems? -- Chapter 72 What is the effect of serious illness on caregivers? -- Chapter 73 What can be done to improve outcomes for caregivers of patients with serious illness? -- Chapter 74 What is prolonged grief disorder and how can its likelihood be reduced? -- Chapter 75 What are the eligibility criteria for hospice? -- Chapter 76 In what settings can hospice be provided? -- Chapter 77 What models exist for delivering palliative care/hospice in nursing homes? -- Chapter 78 How can palliative care be integrated into home-based primary care programs? -- Chapter 79 What new models exist for ambulatory palliative care?
Chapter 80 What new models exist for palliative care in the emergency department? -- Chapter 81 What are sources of spiritual and existential suffering for patients with advances disease?